<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00584753</url>
  </required_header>
  <id_info>
    <org_study_id>200715040</org_study_id>
    <nct_id>NCT00584753</nct_id>
  </id_info>
  <brief_title>Molecular Imaging of Breast Cancer With Breast PET/CT</brief_title>
  <official_title>Molecular Imaging of Breast Cancer With Breast PET/CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a feasibility study to determine if a combined breast PET/CT scanner can image&#xD;
      malignant functional activity while determining anatomical structure in the same clinical&#xD;
      setting for patients with breast cancer. End-points of this study are whether women will&#xD;
      accept the imaging position and timing, and whether functional properties of breast cancer&#xD;
      can be imaged with this device. The secondary purpose of this study is to explore protocol&#xD;
      parameters with a view to optimizing imaging performance whilst minimizing patient&#xD;
      discomfort. Imaging results will be compared to histological samples to determine ground&#xD;
      truth.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PET is literally a molecular imaging modality. In monitoring the patient's response to a&#xD;
      specific chemotherapeutic regime, baseline and subsequent PET/CT scans can be used to&#xD;
      quantitatively determine the therapeutic effect of the regime, using the standard uptake&#xD;
      value (SUV), a common metric in PET imaging. The breast PET/CT system will facilitate&#xD;
      molecular imaging of breast cancer using a number of radiolabeled molecules, available both&#xD;
      commercially (18-FDG) and from the research environment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low enrollment&#xD;
  </why_stopped>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Normal volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breast PET/CT scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Whole body and breast PET/CT</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Positron emission tomography and computed tomography</intervention_name>
    <description>Positron emission tomography and computed tomography</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Breast imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Positron emission tomography and computed tomography</intervention_name>
    <description>Positron emission tomography and computed tomography</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Breast imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Positron emission tomography and computed tomography</intervention_name>
    <description>Positron emission tomography and computed tomography</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Breast imaging</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Normal Adult Volunteers&#xD;
&#xD;
          -  Female, at least 18 years of age&#xD;
&#xD;
          -  Ability to lie motionless for up to 20 minutes&#xD;
&#xD;
        Patient Volunteers&#xD;
&#xD;
          -  Female, at least 18 years of age&#xD;
&#xD;
          -  Diagnostic findings from prior mammography highly suggestive of invasive breast&#xD;
             carcinoma (BI-RADS category 5)&#xD;
&#xD;
          -  Not pregnant or breast-feeding&#xD;
&#xD;
          -  Ability to lie motionless for up to 20 minutes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Normal Adult Volunteers&#xD;
&#xD;
               -  Inability to understand the risks and benefits of the study&#xD;
&#xD;
        Patient Volunteers&#xD;
&#xD;
          -  Recent breast biopsy&#xD;
&#xD;
          -  Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or&#xD;
             lobular carcinoma&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Diabetic and blood sugar level &gt; 200 mg/dL&#xD;
&#xD;
          -  Positive urine pregnancy test or currently breast-feeding&#xD;
&#xD;
          -  Inability to understand the risks and benefits of the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramsey Badawi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC David Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>December 26, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2008</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Ramsey Badawi, Ph.D</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

